? The broad aim of this competing renewal application is to train MD and PhD scientists for research careers in the field of molecular gastroenterology and hepatology. ? The University of Illinois at Chicago (UIC) has a critical mass of MD and PhD scientists whose work focuses on diseases related to the gastrointestinal tract. This group of researchers is highly interactive and has a distinguished record of training MD and PhD scientists in all aspects of investigative gastroenterology. The first funding cycle of this training grant has been highly successful with the first 2 trainees who completed the program having taken faculty positions as Assistant Professors of Medicine at academic institutions. In addition, of the 7 trainees receiving support, 3 are minorities (2 African-Americans and 1 Hispanic) and 5 are women. In addition to this training grant, our faculty has attracted additional federal funding to support junior faculty members during their transition from post-doctoral trainees to independent investigators. ? There are 41 participating faculty associated with this application who are well-funded, study clinical diseases at the bench, and are highly committed to educating fellows in molecular gastroenterology and hepatology. These individuals have an excellent record of developing clinically-orientated MD's into clinician-scientists, and training PhD's in molecular gastroenterology. All preceptors are either a part of, or are formally affiliated with, the Section of Digestive Diseases and Nutrition. The training environment generated within the Section of Digestive Diseases and Nutrition offers a rich mixture of seminars, visiting professors, and conferences that allows for stimulating exchanges between trainees and mentors. Training in molecular gastroenterology and hepatology is under the broad umbrella of gastrointestinal epithelial pathobiology with specific areas of expertise including: GI Cancer, Host-Pathogen Interactions/Inflammation, and Ion Transport. Laboratory work is supplemented with mandatory coursework during the 1st year in Advanced GI Pathophysiology, the Molecular Basis of Growth and Differentiation, Applied Statistical Methods, and Strategies for Effective Scientific Communication ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Institutional National Research Service Award (T32)
Project #
5T32DK007788-09
Application #
7450829
Study Section
Diabetes, Endocrinology and Metabolic Diseases B Subcommittee (DDK)
Program Officer
Densmore, Christine L
Project Start
2000-08-15
Project End
2010-06-30
Budget Start
2008-07-01
Budget End
2009-06-30
Support Year
9
Fiscal Year
2008
Total Cost
$199,833
Indirect Cost
Name
University of Illinois at Chicago
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
098987217
City
Chicago
State
IL
Country
United States
Zip Code
60612
Halasi, Marianna; Hitchinson, Ben; Shah, Binal N et al. (2018) Honokiol is a FOXM1 antagonist. Cell Death Dis 9:84
Yazici, Cemal; Wolf, Patricia G; Kim, Hajwa et al. (2017) Race-dependent association of sulfidogenic bacteria with colorectal cancer. Gut 66:1983-1994
Bul, Vadim; Yazici, Cemal; Staudacher, Jonas J et al. (2017) Multiorgan Failure Predicts Mortality in Emphysematous Pancreatitis: A Case Report and Systematic Analysis of the Literature. Pancreas 46:825-830
Staudacher, Jonas J; Yazici, Cemal; Carroll, Timothy et al. (2017) Activin in acute pancreatitis: Potential risk-stratifying marker and novel therapeutic target. Sci Rep 7:12786
Khan, I; Halasi, M; Zia, M F et al. (2017) Nuclear FOXM1 drives chemoresistance in AML. Leukemia 31:251-255
Halasi, Marianna; Váraljai, Renáta; Benevolenskaya, Elizaveta et al. (2016) A Novel Function of Molecular Chaperone HSP70: SUPPRESSION OF ONCOGENIC FOXM1 AFTER PROTEOTOXIC STRESS. J Biol Chem 291:142-8
Malecki, Elise A; Castellanos, Karla J; Cabay, Robert J et al. (2014) Therapeutic administration of orlistat, rosiglitazone, or the chemokine receptor antagonist RS102895 fails to improve the severity of acute pancreatitis in obese mice. Pancreas 43:903-8
Yazici, Cemal; Niemeyer, David J; Iannitti, David A et al. (2014) Hepatocellular carcinoma and cholangiocarcinoma: an update. Expert Rev Gastroenterol Hepatol 8:63-82
Liu, Hongguang; Singla, Amika; Ao, Mei et al. (2011) Calcitonin receptor-mediated CFTR activation in human intestinal epithelial cells. J Cell Mol Med 15:2697-705
Tencate, Veronica; Sainz Jr, Bruno; Cotler, Scott J et al. (2010) Potential treatment options and future research to increase hepatitis C virus treatment response rate. Hepat Med 2010:125-145

Showing the most recent 10 out of 11 publications